TickerFactsScreenerDevelopers

Clearside Biomedical, Inc. (CLSDQ) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $1.91M2014: $8.27M2015: $20.28M2016: $34.82M2017: $9.22M2018: $8.04M2019: $22.59M2020: $17.29M2021: $30.44M2022: $48.26M2023: $28.92M2024: $20.02M$20.02M
2013Cash & Equivalents (USD)2024
Fiscal YearCash & EquivalentsChange YoY
2024$20.02M-30.8%
2023$28.92M-40.1%
2022$48.26M+58.6%
2021$30.44M+76.1%
2020$17.29M-23.5%
2019$22.59M+180.9%
2018$8.04M-12.8%
2017$9.22M-73.5%
2016$34.82M+71.7%
2015$20.28M+145.3%
2014$8.27M+333.2%
2013$1.91M—